Leng Theodore, Kamboj Georgia, Sun Xiaoyun, Chang Heather, Davda Prisha, Greer Majesty, Stary Creed M
Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, CA, United States.
Department of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Front Ophthalmol (Lausanne). 2023 Apr 14;3:1168650. doi: 10.3389/fopht.2023.1168650. eCollection 2023.
Epiretinal membranes (ERMs) are the result of fibro-cellular proliferation that cause distortion and impairment of central vision. We hypothesized that select microRNAs (miRs) regulate retinal fibro-proliferation and ERM formation. Following IRB approval, a pilot study was performed in patients presenting for retina surgery with and without clinical ERMs. Total RNA was isolated from ERM tissue and controls from non-ERM vitreous and subjected to miR profiling microarray analysis. MiR-494 was identified as the only miR selectively expressed at significantly greater levels, and analysis identified p27 as a putative fibroproliferative gene target of miR-494. testing of miR-494 and p27 in fibrotic transformation was assessed in spontaneously immortalized human retinal pigment epithelial (RPE) and human Müller cell lines, stimulated to transform into a fibroproliferative state transforming growth factor beta (TGFβ). Fibroproliferative transformation was characterized by cellular expression of alpha smooth muscle actin (αSMA). In both RPE and Müller cells, both TGFβ and miR-494 mimic decreased p27 expression. In parallel experiments, transfection with p27 siRNA augmented TGFβ-induced αSMA expression, while only in RPE cells did co-transfection with miR-494 inhibitor decrease αSMA levels. These results demonstrate that miR-494 augments fibrotic transformation in both Müller cells and RPEs, however only in RPEs does miR-494 mediate fibrotic transformation p27. As p27 is known to regulate cellular proliferation and differentiation, future studies should extend clinical testing of miR-494 and/or p27 as a potential novel non-surgical therapy for ERMs, as well as identify relevant miR-494 targets in Müller cells.
视网膜前膜(ERM)是纤维细胞增殖的结果,可导致中心视力扭曲和受损。我们推测特定的微小RNA(miR)调节视网膜纤维增殖和ERM形成。经机构审查委员会(IRB)批准,对有和没有临床ERM的视网膜手术患者进行了一项初步研究。从ERM组织以及非ERM玻璃体的对照中分离出总RNA,并进行miR谱微阵列分析。miR-494被确定为唯一选择性表达水平显著更高的miR,分析确定p27是miR-494的一个假定的纤维增殖基因靶点。在自发永生化的人视网膜色素上皮(RPE)和人Müller细胞系中评估了miR-494和p27在纤维化转化中的作用,这些细胞系被刺激转化为纤维增殖状态,即转化生长因子β(TGFβ)。纤维增殖转化的特征是α平滑肌肌动蛋白(αSMA)的细胞表达。在RPE和Müller细胞中,TGFβ和miR-494模拟物均降低了p27表达。在平行实验中,用p27小干扰RNA(siRNA)转染增强了TGFβ诱导的αSMA表达,而仅在RPE细胞中,与miR-494抑制剂共转染降低了αSMA水平。这些结果表明,miR-494增强了Müller细胞和RPE中的纤维化转化,然而只有在RPE中miR-494通过p27介导纤维化转化。由于已知p27调节细胞增殖和分化,未来的研究应扩展对miR-494和/或p27作为ERM潜在新型非手术治疗方法的临床测试,以及确定Müller细胞中相关的miR-494靶点。